Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Matthew Plunkett. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Matthew Plunkett har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:NKTX / Nkarta, Inc. | Chief Financial Officer | 77 800 |
US:CTIC / CTI BioPharma Corp | EVP, Chief Business Officer, Director | 60 000 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Matthew Plunkett. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp NKTX / Nkarta, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i NKTX / Nkarta, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i NKTX / Nkarta, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Matthew Plunkett som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-07-13 |
|
4 | NKTX |
Nkarta, Inc.
Stock Option (right to buy) |
A - Award | 77 800 | 77 800 | |||||
2020-07-09 | 3 | NKTX |
Nkarta, Inc.
Common Stock |
74 998 | ||||||||
2020-07-09 | 3 | NKTX |
Nkarta, Inc.
Common Stock |
74 998 | ||||||||
2020-07-09 | 3 | NKTX |
Nkarta, Inc.
Common Stock |
74 998 | ||||||||
2017-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Employee Stock Option (Right to Buy) |
A - Award | 60 000 | 60 000 | |||||
2016-03-23 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
F - Taxes | −63 874 | 526 210 | −10,82 | 0,55 | −35 016 | 288 468 | |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −900 | 590 084 | −0,15 | 0,60 | −536 | 351 690 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 220 | 590 984 | −0,21 | 0,60 | −726 | 351 635 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −500 | 592 204 | −0,08 | 0,59 | −297 | 351 769 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 592 704 | −0,19 | 0,59 | −652 | 351 473 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 593 804 | −0,03 | 0,59 | −118 | 351 532 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 594 004 | −0,12 | 0,59 | −414 | 351 056 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 594 704 | −0,12 | 0,59 | −413 | 350 875 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −844 | 595 404 | −0,14 | 0,59 | −497 | 350 693 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 500 | 596 248 | −0,25 | 0,59 | −882 | 350 594 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −636 | 597 748 | −0,11 | 0,59 | −373 | 350 878 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −400 | 598 384 | −0,07 | 0,59 | −234 | 350 653 |
2016-03-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 300 | 598 784 | −0,22 | 0,58 | −760 | 350 289 |
2016-02-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 600 084 | −0,05 | 1,18 | −352 | 705 099 |
2016-02-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 600 384 | −0,12 | 1,17 | −819 | 702 449 |
2016-02-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 601 084 | −0,10 | 1,16 | −696 | 697 257 |
2016-02-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 000 | 601 684 | −0,50 | 1,16 | −3 465 | 694 945 |
2016-02-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 000 | 604 684 | −0,82 | 1,15 | −5 750 | 695 387 |
2016-02-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −400 | 609 684 | −0,07 | 1,14 | −456 | 695 040 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 610 084 | −0,03 | 1,26 | −252 | 768 706 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 610 284 | −0,10 | 1,25 | −750 | 762 855 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −202 | 610 884 | −0,03 | 1,24 | −250 | 757 496 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 611 086 | −0,05 | 1,24 | −370 | 754 691 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 611 386 | −0,13 | 1,23 | −984 | 752 005 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 612 186 | −0,28 | 1,22 | −2 074 | 746 867 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 900 | 613 886 | −0,31 | 1,21 | −2 299 | 742 802 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 615 786 | −0,13 | 1,20 | −964 | 742 022 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 898 | 616 586 | −0,31 | 1,20 | −2 278 | 739 903 |
2016-01-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 600 | 618 484 | −0,26 | 1,20 | −1 912 | 739 088 |
2015-12-23 |
|
4 | ctic |
CTI BIOPHARMA CORP
Employee Stock Option (Right to Buy) |
A - Award | 1 400 000 | 1 400 000 | |||||
2015-12-23 |
|
4 | ctic |
CTI BIOPHARMA CORP
Performance Rights |
D - Sale to Issuer | −253 438 | 0 | −100,00 | ||||
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 620 084 | −0,03 | 1,01 | −202 | 626 285 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 620 284 | −0,02 | 1,00 | −100 | 623 385 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −4 500 | 620 384 | −0,72 | 1,00 | −4 500 | 620 384 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 624 884 | −0,02 | 1,00 | −100 | 624 822 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 624 984 | −0,03 | 1,00 | −200 | 624 859 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 625 184 | −0,05 | 1,00 | −300 | 624 934 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 625 484 | −0,02 | 1,00 | −100 | 625 171 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 625 584 | −0,02 | 1,00 | −100 | 624 020 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 625 684 | −0,10 | 1,00 | −597 | 622 556 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 626 284 | −0,03 | 0,99 | −199 | 623 027 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 626 484 | −0,18 | 0,99 | −1 094 | 623 164 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 627 584 | −0,03 | 0,99 | −199 | 623 505 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 627 784 | −0,03 | 0,99 | −198 | 623 013 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 627 984 | −0,10 | 0,99 | −594 | 621 830 |
2015-12-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 500 | 628 584 | −0,24 | 0,99 | −1 485 | 622 361 |
2015-11-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 400 | 630 084 | −0,22 | 1,40 | −1 960 | 882 118 |
2015-11-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 631 484 | −0,02 | 1,40 | −140 | 880 920 |
2015-11-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 631 584 | −0,17 | 1,39 | −1 529 | 877 902 |
2015-11-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 632 684 | −0,03 | 1,38 | −277 | 876 267 |
2015-11-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 500 | 632 884 | −0,55 | 1,38 | −4 830 | 873 380 |
2015-11-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 800 | 636 384 | −0,28 | 1,38 | −2 475 | 875 028 |
2015-11-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 900 | 638 184 | −0,30 | 1,37 | −2 603 | 874 312 |
2015-10-07 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −584 | 640 084 | −0,09 | 1,53 | −894 | 979 329 |
2015-10-07 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 640 668 | −0,17 | 1,52 | −1 678 | 977 019 |
2015-10-07 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −6 916 | 641 768 | −1,07 | 1,52 | −10 512 | 975 487 |
2015-10-07 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 400 | 648 684 | −0,22 | 1,52 | −2 121 | 982 756 |
2015-10-01 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | −8 394 | 650 084 | −1,27 | 1,43 | −12 003 | 929 620 | |
2015-10-01 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | −100 | 658 478 | −0,02 | 1,42 | −142 | 938 331 | |
2015-10-01 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | −9 092 | 658 578 | −1,36 | 1,42 | −12 911 | 935 181 | |
2015-10-01 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | −5 108 | 667 670 | −0,76 | 1,42 | −7 244 | 946 823 | |
2015-10-01 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | −52 306 | 672 778 | −7,21 | 1,41 | −73 751 | 948 617 | |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −660 | 725 084 | −0,09 | 1,61 | −1 063 | 1 167 385 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 390 | 725 744 | −0,19 | 1,60 | −2 231 | 1 164 819 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −14 400 | 727 134 | −1,94 | 1,60 | −23 040 | 1 163 414 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 500 | 741 534 | −0,20 | 1,60 | −2 392 | 1 182 747 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −16 400 | 743 034 | −2,16 | 1,59 | −26 076 | 1 181 424 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −7 000 | 759 434 | −0,91 | 1,58 | −11 095 | 1 203 703 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 330 | 766 434 | −0,69 | 1,58 | −8 421 | 1 210 966 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 771 764 | −0,13 | 1,58 | −1 575 | 1 215 528 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 772 764 | −0,22 | 1,57 | −2 669 | 1 213 239 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 774 464 | −0,10 | 1,56 | −1 248 | 1 208 164 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 775 264 | −0,10 | 1,55 | −1 240 | 1 201 659 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 776 064 | −0,08 | 1,54 | −927 | 1 199 019 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −289 | 776 664 | −0,04 | 1,54 | −445 | 1 196 063 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 776 953 | −0,01 | 1,54 | −154 | 1 192 623 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −6 899 | 777 053 | −0,88 | 1,53 | −10 555 | 1 188 891 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 783 952 | −0,03 | 1,53 | −306 | 1 197 487 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −13 201 | 784 152 | −1,66 | 1,52 | −20 132 | 1 195 832 |
2015-09-25 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 600 | 797 353 | −0,45 | 1,52 | −5 472 | 1 211 977 |
2015-09-23 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
A - Award | 151 739 | 800 953 | 23,37 | ||||
2015-09-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
common Stock |
S - Sale | X | −1 800 | 649 214 | −0,28 | 1,55 | −2 790 | 1 006 282 |
2015-09-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 651 014 | −0,15 | 1,54 | −1 540 | 1 002 562 |
2015-09-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 652 014 | −0,26 | 1,54 | −2 610 | 1 000 841 |
2015-09-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 500 | 653 714 | −0,83 | 1,53 | −8 415 | 1 000 182 |
2015-09-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
F - Taxes | −12 526 | 659 214 | −1,86 | 1,52 | −19 040 | 1 002 005 | |
2015-08-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 671 740 | −0,01 | 1,85 | −185 | 1 242 719 |
2015-08-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 000 | 671 840 | −0,74 | 1,84 | −9 225 | 1 239 545 |
2015-08-06 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −4 900 | 676 840 | −0,72 | 1,84 | −9 016 | 1 245 386 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 681 740 | −0,03 | 1,98 | −396 | 1 349 845 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 256 | 681 940 | −0,33 | 1,98 | −4 456 | 1 346 832 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −444 | 684 196 | −0,06 | 1,97 | −875 | 1 347 866 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 684 640 | −0,10 | 1,96 | −1 376 | 1 345 318 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 685 340 | −0,15 | 1,96 | −1 960 | 1 343 266 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −400 | 686 340 | −0,06 | 1,95 | −780 | 1 338 363 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 200 | 686 740 | −0,17 | 1,94 | −2 334 | 1 335 709 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 687 940 | −0,25 | 1,93 | −3 281 | 1 327 724 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 689 640 | −0,01 | 1,93 | −193 | 1 329 626 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 689 740 | −0,10 | 1,92 | −1 348 | 1 327 750 |
2015-07-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 300 | 690 440 | −0,19 | 1,92 | −2 496 | 1 325 645 |
2015-06-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 691 740 | −0,01 | 2,08 | −208 | 1 438 819 |
2015-06-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 691 840 | −0,03 | 2,08 | −415 | 1 435 568 |
2015-06-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 700 | 692 040 | −0,53 | 2,07 | −7 659 | 1 432 523 |
2015-06-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 695 740 | −0,01 | 2,06 | −206 | 1 436 703 |
2015-06-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 400 | 695 840 | −0,34 | 2,06 | −4 944 | 1 433 430 |
2015-06-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 698 240 | −0,14 | 2,06 | −2 055 | 1 434 883 |
2015-06-05 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 500 | 699 240 | −0,36 | 2,05 | −5 125 | 1 433 442 |
2015-05-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 701 740 | −0,09 | 1,86 | −1 119 | 1 308 745 |
2015-05-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 000 | 702 340 | −0,43 | 1,86 | −5 580 | 1 306 352 |
2015-05-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 700 | 705 340 | −0,38 | 1,86 | −5 008 | 1 308 406 |
2015-05-04 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 700 | 708 040 | −0,52 | 1,85 | −6 845 | 1 309 874 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 711 740 | −0,04 | 1,92 | −576 | 1 366 541 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 712 040 | −0,01 | 1,92 | −192 | 1 363 557 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 400 | 712 140 | −0,20 | 1,91 | −2 674 | 1 360 187 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 713 540 | −0,01 | 1,90 | −190 | 1 359 294 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 600 | 713 640 | −0,22 | 1,90 | −3 040 | 1 355 916 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 715 240 | −0,01 | 1,90 | −190 | 1 355 380 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 400 | 715 340 | −0,20 | 1,89 | −2 646 | 1 351 993 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 000 | 716 740 | −0,28 | 1,88 | −3 770 | 1 351 055 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 900 | 718 740 | −0,26 | 1,88 | −3 572 | 1 351 231 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −769 | 720 640 | −0,11 | 1,88 | −1 442 | 1 351 200 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 300 | 721 409 | −0,73 | 1,87 | −9 911 | 1 349 035 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 726 709 | −0,11 | 1,86 | −1 492 | 1 355 312 |
2015-04-08 |
|
4 | ctic |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 727 509 | −0,11 | 1,86 | −1 488 | 1 353 167 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 330 | 728 309 | −0,32 | 1,98 | −4 613 | 1 442 052 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 216 | 730 639 | −0,30 | 1,98 | −4 377 | 1 443 012 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 184 | 732 855 | −0,70 | 1,97 | −10 212 | 1 443 724 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −11 700 | 738 039 | −1,56 | 1,96 | −22 990 | 1 450 247 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −28 197 | 749 739 | −3,62 | 1,96 | −55 266 | 1 469 488 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −7 903 | 777 936 | −1,01 | 1,96 | −15 450 | 1 520 865 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 600 | 785 839 | −0,20 | 1,95 | −3 120 | 1 532 386 |
2015-03-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
F - Taxes | −59 784 | 787 439 | −7,06 | 1,94 | −115 682 | 1 523 694 | |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 847 223 | −0,13 | 2,44 | −2 684 | 2 067 224 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 848 323 | −0,02 | 2,44 | −487 | 2 065 667 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 848 523 | −0,07 | 2,43 | −1 458 | 2 061 911 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 849 123 | −0,02 | 2,42 | −485 | 2 059 123 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 800 | 849 323 | −0,33 | 2,42 | −6 776 | 2 055 362 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 852 123 | −0,04 | 2,42 | −724 | 2 057 877 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 852 423 | −0,20 | 2,41 | −4 097 | 2 054 339 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 854 123 | −0,12 | 2,40 | −2 405 | 2 054 166 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 800 | 855 123 | −0,21 | 2,40 | −4 320 | 2 052 295 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 856 923 | −0,13 | 2,40 | −2 634 | 2 052 331 |
2015-03-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 200 | 858 023 | −0,14 | 2,39 | −2 868 | 2 050 675 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 859 223 | −0,02 | 2,26 | −452 | 1 941 844 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 859 423 | −0,07 | 2,25 | −1 350 | 1 933 702 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −500 | 860 023 | −0,06 | 2,24 | −1 120 | 1 926 452 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 860 523 | −0,03 | 2,24 | −670 | 1 923 269 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 600 | 860 823 | −0,19 | 2,23 | −3 568 | 1 919 635 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 862 423 | −0,09 | 2,22 | −1 780 | 1 918 891 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 700 | 863 223 | −0,43 | 2,22 | −8 214 | 1 916 355 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 866 923 | −0,13 | 2,22 | −2 436 | 1 920 234 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 900 | 868 023 | −0,22 | 2,21 | −4 199 | 1 918 331 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 869 923 | −0,02 | 2,20 | −441 | 1 918 180 |
2015-02-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 870 123 | −0,13 | 2,20 | −2 420 | 1 914 271 |
2015-01-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
A - Award | 477 255 | 871 223 | 121,14 | ||||
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 393 968 | −0,25 | 2,38 | −2 375 | 935 674 |
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 700 | 394 968 | −1,42 | 2,37 | −13 509 | 936 074 |
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 400 668 | −0,15 | 2,36 | −1 419 | 947 580 |
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 300 | 401 268 | −0,57 | 2,36 | −5 428 | 946 992 |
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 403 568 | −0,25 | 2,36 | −2 355 | 950 403 |
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 404 568 | −0,02 | 2,35 | −235 | 950 735 |
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 404 668 | −0,07 | 2,34 | −704 | 948 946 |
2015-01-07 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 404 968 | −0,25 | 2,34 | −2 340 | 947 625 |
2014-12-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 200 | 405 968 | −0,29 | 2,25 | −2 700 | 913 428 |
2014-12-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −400 | 407 168 | −0,10 | 2,24 | −898 | 914 092 |
2014-12-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 407 568 | −0,07 | 2,24 | −672 | 912 952 |
2014-12-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 900 | 407 868 | −0,95 | 2,24 | −8 716 | 911 585 |
2014-12-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 400 | 411 768 | −1,29 | 2,23 | −12 042 | 918 243 |
2014-12-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 417 168 | −0,14 | 2,22 | −1 335 | 928 199 |
2014-12-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 417 768 | −0,05 | 2,22 | −444 | 927 445 |
2014-11-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 417 968 | −0,41 | 2,40 | −4 088 | 1 005 213 |
2014-11-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 419 668 | −0,24 | 2,40 | −2 400 | 1 007 203 |
2014-11-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 420 668 | −0,19 | 2,40 | −1 916 | 1 007 500 |
2014-11-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 400 | 421 468 | −0,57 | 2,39 | −5 736 | 1 007 309 |
2014-11-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 500 | 423 868 | −0,59 | 2,38 | −5 962 | 1 010 925 |
2014-11-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 700 | 426 368 | −0,63 | 2,38 | −6 429 | 1 015 182 |
2014-11-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −900 | 429 068 | −0,21 | 2,37 | −2 133 | 1 016 891 |
2014-10-08 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 429 968 | −0,23 | 2,41 | −2 410 | 1 036 223 |
2014-10-08 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 430 968 | −0,02 | 2,40 | −240 | 1 036 478 |
2014-10-08 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 138 | 431 068 | −0,49 | 2,40 | −5 131 | 1 034 563 |
2014-10-08 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −4 200 | 433 206 | −0,96 | 2,40 | −10 059 | 1 037 528 |
2014-10-08 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 062 | 437 406 | −0,70 | 2,39 | −7 318 | 1 045 400 |
2014-10-08 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 440 468 | −0,18 | 2,38 | −1 908 | 1 050 516 |
2014-10-08 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 441 268 | −0,16 | 2,38 | −1 666 | 1 050 218 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 600 | 441 968 | −0,36 | 2,58 | −4 128 | 1 140 277 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 443 568 | −0,14 | 2,57 | −1 542 | 1 139 970 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −9 250 | 444 168 | −2,04 | 2,56 | −23 680 | 1 137 070 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −14 118 | 453 418 | −3,02 | 2,55 | −36 001 | 1 156 216 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 300 | 467 536 | −0,70 | 2,54 | −8 382 | 1 187 541 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 600 | 470 836 | −0,55 | 2,53 | −6 578 | 1 191 215 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −722 | 473 436 | −0,15 | 2,52 | −1 819 | 1 193 059 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −15 728 | 474 158 | −3,21 | 2,51 | −39 477 | 1 190 137 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 900 | 489 886 | −0,79 | 2,50 | −9 750 | 1 224 715 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 200 | 493 786 | −0,44 | 2,63 | −5 786 | 1 298 657 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 635 | 495 986 | −0,53 | 2,62 | −6 904 | 1 299 483 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 408 | 498 621 | −0,28 | 2,61 | −3 675 | 1 301 401 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 901 | 500 029 | −0,77 | 2,60 | −10 143 | 1 300 075 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 793 | 503 930 | −0,55 | 2,59 | −7 234 | 1 305 179 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −27 400 | 506 723 | −5,13 | 2,58 | −70 692 | 1 307 345 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 000 | 534 123 | −0,56 | 2,57 | −7 710 | 1 372 696 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −981 | 537 123 | −0,18 | 2,56 | −2 511 | 1 375 035 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 538 104 | −0,06 | 2,55 | −765 | 1 372 165 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 538 404 | −0,06 | 2,54 | −762 | 1 367 546 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −3 500 | 538 704 | −0,65 | 2,53 | −8 855 | 1 362 921 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −799 | 542 204 | −0,15 | 2,52 | −2 013 | 1 366 354 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 500 | 543 003 | −0,28 | 2,51 | −3 765 | 1 362 938 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 544 503 | −0,11 | 2,50 | −1 500 | 1 361 258 |
2014-09-24 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −500 | 545 103 | −0,09 | 2,49 | −1 245 | 1 357 306 |
2014-09-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 630 | 545 603 | −0,30 | 2,49 | −4 059 | 1 358 551 |
2014-09-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 547 233 | −0,02 | 2,49 | −249 | 1 361 516 |
2014-09-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 200 | 547 333 | −0,40 | 2,48 | −5 467 | 1 360 123 |
2014-09-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −8 901 | 549 533 | −1,59 | 2,48 | −22 074 | 1 362 842 |
2014-09-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −5 500 | 558 434 | −0,98 | 2,48 | −13 612 | 1 382 124 |
2014-09-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −8 870 | 563 934 | −1,55 | 2,47 | −21 909 | 1 392 917 |
2014-09-05 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 572 804 | −0,02 | 2,46 | −246 | 1 411 962 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 572 904 | −0,05 | 2,53 | −759 | 1 449 447 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 573 204 | −0,05 | 2,52 | −756 | 1 444 474 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 573 504 | −0,02 | 2,52 | −252 | 1 442 363 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 500 | 573 604 | −0,26 | 2,51 | −3 765 | 1 439 746 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 575 104 | −0,02 | 2,50 | −250 | 1 440 636 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 575 204 | −0,14 | 2,50 | −2 000 | 1 438 010 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 576 004 | −0,17 | 2,50 | −2 495 | 1 437 130 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 577 004 | −0,10 | 2,49 | −1 494 | 1 436 740 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −400 | 577 604 | −0,07 | 2,48 | −994 | 1 435 346 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 578 004 | −0,03 | 2,48 | −496 | 1 433 450 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 578 204 | −0,14 | 2,47 | −1 976 | 1 428 164 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 579 004 | −0,10 | 2,46 | −1 479 | 1 427 245 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 000 | 579 604 | −0,34 | 2,46 | −4 920 | 1 425 826 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 100 | 581 604 | −0,19 | 2,46 | −2 700 | 1 427 838 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 300 | 582 704 | −0,22 | 2,45 | −3 185 | 1 427 625 |
2014-08-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −900 | 584 004 | −0,15 | 2,44 | −2 200 | 1 427 890 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 584 904 | −0,10 | 2,96 | −1 776 | 1 731 316 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 585 504 | −0,03 | 2,96 | −591 | 1 730 164 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 585 704 | −0,03 | 2,94 | −588 | 1 721 970 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 585 904 | −0,10 | 2,94 | −1 761 | 1 719 628 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 586 504 | −0,29 | 2,93 | −4 981 | 1 718 457 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −900 | 588 204 | −0,15 | 2,92 | −2 632 | 1 720 497 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 700 | 589 104 | −0,29 | 2,92 | −4 964 | 1 720 184 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 590 804 | −0,10 | 2,90 | −1 740 | 1 713 332 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 591 404 | −0,10 | 2,88 | −1 728 | 1 703 244 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 592 004 | −0,03 | 2,86 | −573 | 1 696 091 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −600 | 592 204 | −0,10 | 2,86 | −1 716 | 1 693 703 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −500 | 592 804 | −0,08 | 2,86 | −1 428 | 1 692 455 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 000 | 593 304 | −0,17 | 2,85 | −2 850 | 1 690 916 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −900 | 594 304 | −0,15 | 2,84 | −2 560 | 1 690 795 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 595 204 | −0,13 | 2,84 | −2 272 | 1 690 379 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 596 004 | −0,02 | 2,84 | −284 | 1 689 671 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −500 | 596 104 | −0,08 | 2,82 | −1 410 | 1 681 013 |
2014-07-09 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 596 604 | −0,05 | 2,82 | −844 | 1 679 440 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −200 | 596 904 | −0,03 | 3,07 | −614 | 1 832 495 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −500 | 597 104 | −0,08 | 3,06 | −1 530 | 1 827 138 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 597 604 | −0,12 | 3,05 | −2 135 | 1 822 692 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −800 | 598 304 | −0,13 | 3,04 | −2 436 | 1 821 836 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 189 | 599 104 | −0,20 | 3,04 | −3 615 | 1 821 276 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −100 | 600 293 | −0,02 | 3,04 | −304 | 1 821 889 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 600 393 | −0,12 | 3,03 | −2 121 | 1 819 191 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 601 093 | −0,05 | 3,02 | −908 | 1 818 306 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 300 | 601 393 | −0,38 | 3,02 | −6 946 | 1 816 207 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −1 200 | 603 693 | −0,20 | 3,02 | −3 618 | 1 820 134 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −2 100 | 604 893 | −0,35 | 3,01 | −6 321 | 1 820 728 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −900 | 606 993 | −0,15 | 3,00 | −2 704 | 1 824 014 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −11 | 607 893 | 0,00 | 3,00 | −33 | 1 823 679 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −300 | 607 904 | −0,05 | 2,98 | −892 | 1 808 514 |
2014-06-06 |
|
4 | CTIC |
CTI BIOPHARMA CORP
Common Stock |
S - Sale | X | −700 | 608 204 | −0,11 | 2,97 | −2 079 | 1 806 366 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −38 | 608 904 | −0,01 | 2,98 | −113 | 1 814 534 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −700 | 608 942 | −0,11 | 2,98 | −2 082 | 1 811 602 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −3 517 | 609 642 | −0,57 | 2,97 | −10 445 | 1 810 637 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −100 | 613 159 | −0,02 | 2,97 | −297 | 1 819 856 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −2 400 | 613 259 | −0,39 | 2,96 | −7 116 | 1 818 313 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −1 300 | 615 659 | −0,21 | 2,96 | −3 848 | 1 822 351 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −400 | 616 959 | −0,06 | 2,96 | −1 182 | 1 823 114 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −745 | 617 359 | −0,12 | 2,95 | −2 198 | 1 821 209 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −1 100 | 618 104 | −0,18 | 2,94 | −3 234 | 1 817 226 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −300 | 619 204 | −0,05 | 2,94 | −880 | 1 817 364 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −1 100 | 619 504 | −0,18 | 2,93 | −3 223 | 1 815 147 |
2014-05-07 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | X | −300 | 620 604 | −0,05 | 2,92 | −878 | 1 815 267 |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −1 000 | 620 904 | −0,16 | 3,76 | −3 755 | 2 331 495 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −1 100 | 621 904 | −0,18 | 3,75 | −4 127 | 2 333 384 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −300 | 623 004 | −0,05 | 3,75 | −1 125 | 2 336 265 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −200 | 623 304 | −0,03 | 3,75 | −750 | 2 336 767 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −300 | 623 504 | −0,05 | 3,75 | −1 124 | 2 336 893 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −100 | 623 804 | −0,02 | 3,75 | −375 | 2 337 394 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −14 000 | 623 904 | −2,19 | 3,74 | −52 430 | 2 336 520 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −400 | 637 904 | −0,06 | 3,74 | −1 497 | 2 387 037 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −9 000 | 638 304 | −1,39 | 3,74 | −33 660 | 2 387 257 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −100 | 647 304 | −0,02 | 3,74 | −374 | 2 420 270 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −10 800 | 647 404 | −1,64 | 3,74 | −40 338 | 2 418 054 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −1 400 | 658 204 | −0,21 | 3,73 | −5 225 | 2 456 417 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −400 | 659 604 | −0,06 | 3,73 | −1 492 | 2 460 983 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −18 600 | 660 004 | −2,74 | 3,73 | −69 378 | 2 461 815 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −22 086 | 678 604 | −3,15 | 3,72 | −82 270 | 2 527 800 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −300 | 700 690 | −0,04 | 3,72 | −1 117 | 2 607 968 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −2 500 | 700 990 | −0,36 | 3,72 | −9 302 | 2 608 384 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −68 656 | 703 490 | −8,89 | 3,72 | −255 400 | 2 616 983 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −10 158 | 772 146 | −1,30 | 3,72 | −37 737 | 2 868 522 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −600 | 782 304 | −0,08 | 3,71 | −2 227 | 2 903 912 | |
2014-03-21 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
S - Sale | −8 000 | 782 904 | −1,01 | 3,71 | −29 680 | 2 904 574 | |
2014-01-31 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
A - Award | 394 199 | 790 904 | 99,37 | ||||
2013-12-12 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Stock Option (right to buy) |
A - Award | 300 000 | 300 000 | |||||
2013-03-22 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Performance Rights |
A - Award | 253 438 | 253 438 | |||||
2013-03-22 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
A - Award | 296 705 | 396 705 | 296,70 | ||||
2012-10-18 |
|
4 | CTIC |
CELL THERAPEUTICS INC
Common Stock |
A - Award | 100 000 | 100 000 |